Hansa Biopharma AB (publ) (STO: HNSA)
Sweden
· Delayed Price · Currency is SEK
40.08
+1.04 (2.66%)
Oct 4, 2024, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.72 billion as of October 4, 2024. Its market cap has increased by 42.85% in one year.
Market Cap
2.72B
Enterprise Value
2.99B
Revenue
163.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.08
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.72B, an increase of 8,749.85%. That is a compound annual growth rate of 31.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca PLC | 2,509.03B |
Swedish Orphan Biovitrum AB (publ) | 104.95B |
Getinge AB (publ) | 58.75B |
Sectra AB (publ) | 54.60B |
Camurus AB (publ) | 37.87B |
Vitrolife AB (publ) | 33.66B |
Medicover AB (publ) | 27.66B |
Elekta AB (publ) | 26.76B |